Sano blog | neurodegenerative disease (2)

precision medicine neurodegenerative disease podcast recap

Podcast recap: Sal Rico on gene therapy breakthroughs, safety lessons, and what’s next for precision neurology

In a recent episode of The Genetics Podcast, Patrick spoke with Dr. Sal Rico, Chief Medical Officer at Encoded Therapeutics. Having worked across small molecule...

biomarkers neurodegenerative disease podcast recap

Podcast recap: Genomics-driven drug discovery with Dr. Eric Green

In the latest episode of The Genetics Podcast, host and Sano Genetics CEO Patrick Short welcomes Dr. Eric Green, CEO and Founder of Trace Neuroscience. Eric has...

precision medicine neurodegenerative disease health equity

Overcoming challenges in precision neurology

Implementing precision neurology comes with its own set of complexities—from decoding the brain's intricate workings to addressing the ethical challenges of usi...

patient recruitment neurodegenerative disease

Neuron23 Unveils Groundbreaking Phase 2 Trial in Early Parkinson’s Disease

Sano is proud to support Neuron23 in the NEULARK Phase 2 clinical trial, a groundbreaking study exploring NEU-411, a brain-penetrant LRRK2 inhibitor with the po...

biomarkers genetic testing neurodegenerative disease

What’s driving progress in precision neurology?

Precision medicine is transforming neurology by enabling more accurate diagnoses and tailored treatments. Here, we explore key components driving this progress,...

precision medicine neurodegenerative disease Alzheimer's disease

How precision medicine is transforming neurological health care

Millions of people worldwide are affected by neurological disorders like ALS, Alzheimer’s, and Parkinson’s. These conditions bring unique challenges for patient...

rare disease neurodegenerative disease

Innovating for impact: How natural history studies pave the way for rare disease therapies [webinar recap]

In a recent webinar, former Reata Pharmaceuticals CEO Warren Huff shared his journey leading the company from its founding in 2002 to its landmark acquisition b...

neurodegenerative disease Alzheimer's disease podcast recap

Podcast recap: Q2 insights with Dr. Veera Rajagopal

In the most recent episode of The Genetics Podcast, Sano CEO Dr. Patrick Short explored the latest discoveries in genetics and precision medicine with returning...

patient recruitment neurodegenerative disease patient engagement

Webinar recap: Parkinson's disease engagement, screening, and retention

In this webinar, “Parkinson's disease: Engagement, screening, and retention," Sano CEO and Co-Founder Patrick Short shares a case study of Sano’s work on a gene...